Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Cerullo

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Journal of Extracellular Vesicles|August 19, 2017
Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesiclesElisa Lázaro-Ibáñez, Maarit Neuvonen, Maarit Takatalo, et al.
Frontiers in Oncology|June 7, 2022
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse ModelMaria Vitale, Filippo Scialò, Margherita Passariello, et al.
Oncoimmunology|September 22, 2017
A novel <i>in silico</i> framework to improve MHC-I epitopes and break the tolerance to melanomaCristian Capasso, Aniket Magarkar, Victor Cervera-Carrascon, et al.
International Journal of Cancer|July 1, 2014
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcomaMikko Siurala, Simona Bramante, Lotta Vassilev, et al.
Journal of Extracellular Vesicles|May 5, 2020
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA deliveryHeikki Saari, Tiia Turunen, Andres Lõhmus, et al.
Human Gene Therapy|August 15, 2012
Capsid-modified adenoviral vectors for improved muscle-directed gene therapyKilian Guse, Masataka Suzuki, Gautam Sule, et al.
International Journal of Pharmaceutics|November 12, 2024
Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cellsAndrea Patrizia Falanga, Francesca Greco, Monica Terracciano, et al.
International Journal of Cancer|August 12, 2011
Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancerLotta Kangasniemi, Suvi Parviainen, Tommi Pisto, et al.
Materials Today. Bio|January 21, 2026
Design and <i>in vitro</i> validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanomaKhalil Elbadri, Manlio Fuscielo, Firas Hamdan, et al.
Bioactive Materials|December 6, 2024
Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patchesCarmine D'Amico, Manlio Fusciello, Firas Hamdan, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Journal of Extracellular Vesicles|August 19, 2017
Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesiclesElisa Lázaro-Ibáñez, Maarit Neuvonen, Maarit Takatalo, et al.
Frontiers in Oncology|June 7, 2022
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse ModelMaria Vitale, Filippo Scialò, Margherita Passariello, et al.
Oncoimmunology|September 22, 2017
A novel <i>in silico</i> framework to improve MHC-I epitopes and break the tolerance to melanomaCristian Capasso, Aniket Magarkar, Victor Cervera-Carrascon, et al.
International Journal of Cancer|July 1, 2014
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcomaMikko Siurala, Simona Bramante, Lotta Vassilev, et al.
Journal of Extracellular Vesicles|May 5, 2020
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA deliveryHeikki Saari, Tiia Turunen, Andres Lõhmus, et al.
Human Gene Therapy|August 15, 2012
Capsid-modified adenoviral vectors for improved muscle-directed gene therapyKilian Guse, Masataka Suzuki, Gautam Sule, et al.
International Journal of Pharmaceutics|November 12, 2024
Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cellsAndrea Patrizia Falanga, Francesca Greco, Monica Terracciano, et al.
International Journal of Cancer|August 12, 2011
Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancerLotta Kangasniemi, Suvi Parviainen, Tommi Pisto, et al.
Materials Today. Bio|January 21, 2026
Design and <i>in vitro</i> validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanomaKhalil Elbadri, Manlio Fuscielo, Firas Hamdan, et al.
Bioactive Materials|December 6, 2024
Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patchesCarmine D'Amico, Manlio Fusciello, Firas Hamdan, et al.
Pageof 14